Receptor Structure
Receptor Structure - Related Videos
01:03
Olfactory Receptors: Location and Structure
0 Views •
2024
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
11:31
Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella
0 Views •
Cited by 1 •
2018
In this article, we describe the protocols of protein expression, purification, crystallization and structure determination of the N-terminal domain of ryanodine receptor from diamondback moth (Plutella xylostella).
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
0 Views •
Cited by 14 •
2016
Here we present a protocol to describe the localization of angiotensin II Type 1 receptors in the rat brain by quantitative, densitometric, in vitro receptor autoradiography using an iodine-125 labeled analog of angiotensin II.
12:27
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
0 Views •
Cited by 3 •
2022
S1P exerts its diverse physiological effects through the S1P receptors (S1PRs) subfamily. Here, a pipeline is described to expound on the structures and function of S1PRs.
10:14
Retroviral Transduction of T-cell Receptors in Mouse T-cells
0 Views •
Cited by 21 •
2010
We present a protocol to produce antigen-specific mouse T-cells using retroviral...
FAQs
Binding pockets, transmembrane domains, and intracellular regions contribute different structural information about receptor behavior. The pocket helps determine which ligands can bind, while transmembrane and intracellular regions influence how binding-related conformational changes connect with cellular signaling. Examining these regions together helps explain why compounds can differ in affinity, selectivity, efficacy, and the duration of their effects.
After a ligand occupies its site, the receptor may stabilize a conformation associated with activation, inhibition, or altered downstream signaling. Thus, binding alone does not fully predict pharmacological response: the structural state favored by the ligand matters. This distinction helps account for compounds that interact with the same receptor yet produce different functional outcomes or signal duration.
Affinity concerns how strongly a ligand interacts with its binding site, whereas efficacy concerns the response associated with the receptor state it stabilizes. Structural differences among binding sites or receptor regions can also favor interaction with one receptor over others. These relationships help explain how structural organization supports selective drug action and potentially reduces off-target effects.
Drug discovery can use structural information to relate a candidate compound's interactions with a binding pocket to its expected pharmacological behavior. Researchers can then seek compounds with improved therapeutic activity while reducing interactions with unintended receptors. This structure-guided reasoning is especially useful when affinity, selectivity, efficacy, and downstream signaling must be considered together.
Structural analysis can connect receptor organization with changes in drug response. By examining binding pockets, transmembrane domains, and intracellular regions, investigators can consider how ligand recognition and downstream signaling may be altered in situations involving reduced drug effectiveness. This perspective helps explain drug resistance without treating receptor binding as an isolated event.
Understanding receptor structure provides a framework for interpreting differences in patient responses. Structural features can influence ligand affinity, selectivity, efficacy, and signal duration, so changes in how a drug interacts with its receptor may alter the resulting cellular effect. This pharmacological context helps connect molecular organization with variation in therapeutic outcomes.